RETRACTED: Zulfiqar et al. Obesity and Frailty Syndrome in the Elderly: Prospective Study in Primary Care. Medicines 2022, 9, 38

The journal retracts the article titled “Obesity and Frailty Syndrome in the Elderly: Prospective Study in Primary Care” [1], cited above.

Following publication, concerns were brought to the attention of the Editorial Office regarding the extent to which this article [1] adheres to national regulations governing research involving human participants.

Adhering to our complaints procedure, the Editorial Office and Editorial Board conducted an investigation that concluded that this study falls under a prospective observational study classification, which requires validation and approval from the national ethics committee (CPP) before patient inclusion according to the guidance of the French laws for clinical research. Taking into consideration that this study is missing mandatory ethical validation from the CPP, the Editorial Board concluded that this study does not adhere to the national regulations governing research involving human participants. As a result, the Editorial Board have concluded that this study did not receive the required level of ethical oversight and have decided to retract this publication [1], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).

This retraction was approved by the Editor-in Chief of the Medicines journal.

The authors did not agree to this retraction.